Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Clinical trial NCT05794230 · COMPLETED

Trial details

NCT number: NCT05794230
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Immunisation Healthy Volunteers

Start date: 2023-03-27
Primary completion: 2025-11-15
Enrollment: 1528

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.